Literature DB >> 11983017

The production of transgenic pigs for potential use in clinical xenotransplantation: microbiological evaluation.

Alexander Tucker1, Carolyn Belcher, Badru Moloo, Judith Bell, Tony Mazzulli, Atul Humar, Allison Hughes, Peter McArdle, Antony Talbot.   

Abstract

Debate over the infection hazards of pig-to-human xenotransplantation has focused mainly on the porcine endogenous retroviruses (PERV). However, hazards of exogenous infectious agents possibly associated with the xenograft have also been evaluated (Xenotransplantation 2000; 7: 143). We report the results of a health monitoring program demonstrating the exclusion of more than 80 potential pathogens from nine cohorts of pigs reared in a high welfare bioexclusion facility as potential xenograft source animals. A dynamic bacterial flora of pigs reared under barrier conditions was characterized, emphasizing the significance of monitoring for multiresistant antimicrobial sensitivity patterns. Evidence was found for exclusion of two commonly residual exogenous viruses, porcine cytomegalovirus and porcine lymphotropic herpesviruses, among a proportion of the cohorts tested. Finally, there was histopathological evidence for low grade pneumonitis among sentinel pigs, likely to have been associated with the use of quaternary ammonium disinfectants during the production process, indicating a need for review of toxicology data for disinfectant agents used in such bioexclusion systems. Intensive health monitoring programs, based upon regularly updated recommendations from the microbiological research community, will enable significant reductions in the potential hazards associated with pig-to-human xenotransplantation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11983017     DOI: 10.1034/j.1399-3089.2002.01050.x

Source DB:  PubMed          Journal:  Xenotransplantation        ISSN: 0908-665X            Impact factor:   3.907


  7 in total

1.  Challenges facing islet transplantation for the treatment of type 1 diabetes mellitus.

Authors:  Kristina I Rother; David M Harlan
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

2.  Determinants of high titer in recombinant porcine endogenous retroviruses.

Authors:  Ian Harrison; Yasuhiro Takeuchi; Birke Bartosch; Jonathan P Stoye
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

Review 3.  Infection barriers to successful xenotransplantation focusing on porcine endogenous retroviruses.

Authors:  Joachim Denner; Ralf R Tönjes
Journal:  Clin Microbiol Rev       Date:  2012-04       Impact factor: 26.132

4.  Up to 9-day survival and control of thrombocytopenia following alpha1,3-galactosyl transferase knockout swine liver xenotransplantation in baboons.

Authors:  Karen Kim; Christian Schuetz; Nahel Elias; Gregory R Veillette; Isaac Wamala; Manish Varma; R Neal Smith; Simon C Robson; A Benedict Cosimi; David H Sachs; Martin Hertl
Journal:  Xenotransplantation       Date:  2012 Jul-Aug       Impact factor: 3.907

5.  Absence of replication-competent human-tropic porcine endogenous retroviruses in the germ line DNA of inbred miniature Swine.

Authors:  Linda Scobie; Samantha Taylor; James C Wood; Kristen M Suling; Gary Quinn; Sharon Meikle; Clive Patience; Henk-Jan Schuurman; David E Onions
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

6.  Relative age of proviral porcine endogenous retrovirus sequences in Sus scrofa based on the molecular clock hypothesis.

Authors:  Ralf R Tönjes; Marcus Niebert
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

7.  Screening and Identification of the First Non-CRISPR/Cas9-Treated Chinese Miniature Pig With Defective Porcine Endogenous Retrovirus pol Genes.

Authors:  Yuyuan Ma; Junting Jia; Rui Fan; Ying Lu; Xiong Zhao; Yadi Zhong; Jierong Yang; Limin Ma; Yanlin Wang; Maomin Lv; Haiyuan Yang; Lisha Mou; Yifan Dai; Shutang Feng; Jingang Zhang
Journal:  Front Immunol       Date:  2022-01-19       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.